1-(4-chloro-6-morpholin-4-yl-2-pyridinyl)pyrrolidin-2-one;4-(4,6-dichloro-2-pyridinyl)morpholine;(3S)-N-[4-methyl-3-[2-morpholin-4-yl-6-(2-oxopyrrolidin-1-yl)-4-pyridinyl]phenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;(3S)-N-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;pyrrolidin-2-one
C73H93BCl3F6N13O10 — CID 159864946
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(4-chloro-6-morpholin-4-yl-2-pyridinyl)pyrrolidin-2-one;4-(4,6-dichloro-2-pyridinyl)morpholine;(3S)-N-[4-methyl-3-[2-morpholin-4-yl-6-(2-oxopyrrolidin-1-yl)-4-pyridinyl]phenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;(3S)-N-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;pyrrolidin-2-one
1-(4-chloro-6-morpholin-4-yl-2-pyridinyl)pyrrolidin-2-one;4-(4,6-dichloro-2-pyridinyl)morpholine;(3S)-N-[4-methyl-3-[2-morpholin-4-yl-6-(2-oxopyrrolidin-1-yl)-4-pyridinyl]phenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;(3S)-N-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;pyrrolidin-2-one (PubChem CID 159864946) has the molecular formula C73H93BCl3F6N13O10 and a molecular weight of 1543.79 g/mol. Its IUPAC name is 1-(4-chloro-6-morpholin-4-yl-2-pyridinyl)pyrrolidin-2-one;4-(4,6-dichloro-2-pyridinyl)morpholine;(3S)-N-[4-methyl-3-[2-morpholin-4-yl-6-(2-oxopyrrolidin-1-yl)-4-pyridinyl]phenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;(3S)-N-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;pyrrolidin-2-one.
Molecular Properties
| Compound Name | 1-(4-chloro-6-morpholin-4-yl-2-pyridinyl)pyrrolidin-2-one;4-(4,6-dichloro-2-pyridinyl)morpholine;(3S)-N-[4-methyl-3-[2-morpholin-4-yl-6-(2-oxopyrrolidin-1-yl)-4-pyridinyl]phenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;(3S)-N-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;pyrrolidin-2-one |
|---|---|
| PubChem CID | 159864946 |
| Molecular Formula | C73H93BCl3F6N13O10 |
| Molecular Weight | 1543.79 g/mol |
| Exact Mass | 1541.62 |
| IUPAC Name | 1-(4-chloro-6-morpholin-4-yl-2-pyridinyl)pyrrolidin-2-one;4-(4,6-dichloro-2-pyridinyl)morpholine;(3S)-N-[4-methyl-3-[2-morpholin-4-yl-6-(2-oxopyrrolidin-1-yl)-4-pyridinyl]phenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;(3S)-N-[4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;pyrrolidin-2-one |
| SMILES | Cc1ccc(NC(=O)N2CC[C@@H](CC(F)(F)F)C2)cc1-c1cc(N2CCOCC2)nc(N2CCCC2=O)c1.Cc1ccc(NC(=O)N2CC[C@@H](CC(F)(F)F)C2)cc1B1OC(C)(C)C(C)(C)O1.Clc1cc(Cl)nc(N2CCOCC2)c1.O=C1CCCN1.O=C1CCCN1c1cc(Cl)cc(N2CCOCC2)n1 |
| InChI | InChI=1S/C27H32F3N5O3.C20H28BF3N2O3.C13H16ClN3O2.C9H10Cl2N2O.C4H7NO/c1-18-4-5-21(31-26(37)34-8-6-19(17-34)16-27(28,29)30)15-22(18)20-13-23(33-9-11-38-12-10-33)32-24(14-20)35-7-2-3-25(35)36;1-13-6-7-15(10-16(13)21-28-18(2,3)19(4,5)29-21)25-17(27)26-9-8-14(12-26)11-20(22,23)24;14-10-8-11(16-4-6-19-7-5-16)15-12(9-10)17-3-1-2-13(17)18;10-7-5-8(11)12-9(6-7)13-1-3-14-4-2-13;6-4-2-1-3-5-4/h4-5,13-15,19H,2-3,6-12,16-17H2,1H3,(H,31,37);6-7,10,14H,8-9,11-12H2,1-5H3,(H,25,27);8-9H,1-7H2;5-6H,1-4H2;1-3H2,(H,5,6)/t19-;14-;;;/m00.../s1 |
| InChIKey | NRPQPDARTWQGBC-CUPKJWGSSA-N |
| XLogP | 12.75 |
| TPSA | 228.94 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 106 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1543.79 |
| LogP ≤ 5 | 12.75 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159864946 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.